Regulatory Compliance in API Drug Production of Different Countries
Active pharmaceutical ingredients, also known as APIs, refer to the biologically active components of drugs that provide pharmacological activity or direct action.
January 2, 2024
by PharmaSources
Centre provides over 42 crore vaccine doses to states and UTs
Over 2.11 crore balance and unutilised doses still available with states and Union Territories (UTs), and private hospitals.
July 20, 2021
by expresspharma
Supply scarcity is delaying full scale production of COVID-19 vaccine: Novavax
Novavax has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses per month until the third quarter due to supply shortages including bags used to grow cells, a company spokeswoman told Reuters.
April 15, 2021
by expresspharma
Agilent continues to focus on strategic M&A, R&D investment to expand product portfolio
Samir Vyas, Country Manager, Agilent India says India companies are now moving into the global biopharma market and gives his views on the role of policies like Make in India/Atmanirbhar Bharat, a more vigilant US FDA after the sartan episode and ...
March 15, 2021
by expresspharma
Industry stakeholders raise concerns about price increase of PVC granules
The industry has indicated that it will suspend production of few products till the time price gets streamlined.
January 18, 2021
by expresspharma
India’s role in global supply of COVID-19 drugs and vaccines remains crucial despite IPR waiver decision: GlobalData
Following the news that the US and EU have blocked India’s fight for intellectual property rights (IPR) waiver for COVID-19 drugs; Prashant Khadayate, Pharma Analyst at GlobalData, offers his view.
October 22, 2020
by expresspharma
Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply
Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Plant 3 as...
September 22, 2020
by prnasia
CDSCO extends consent to import drugs with less than 60 per cent residual shelf life by three months
The DCGI has taken this decision after considering the current situation in the country and the need for uninterrupted supply of medicines.
July 14, 2020
by expresspharma
Experts ask govt to ensure access to remdesivir, raise concerns about supply shortage
Many also allude to an emerging black market for remdesivir in the country through which the drug is being sold at exorbitant prices per vial.
July 7, 2020
by expresspharma
Pharmaceutical product shortage and imbalance between supply and demand of global APIs
Globally, the R&D of therapeutic drugs and prophylactic vaccines still needs time, and each country can only rely on the prevention and control method of early diagnosis and early isolation.
May 20, 2020
by Xiaoyaowan
Nation works at full capacity to supply medical goods to world
China will work at top capacity to provide assistance to the international community and further enhance quality control over exports of medical supplies to better aid the global battle against the COVID-19 outbreak, officials said on April 26.
April 27, 2020
by chinadaily
All efforts are being made to improve availability of medicines in India: Pharma Minister
The Minister also asked officers to maintain close coordination within themselves and with other concerned ministries to ensure supply of essential items without any hindrance.
April 22, 2020
by expresspharma